Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galina M Proshkina

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nanomaterials (Basel, Switzerland)|December 24, 2025
DNA Unwinding Driven by Gold NanoparticlesLiat Katrivas, Galina M Proshkina, Sergey M Deyev, et al.
Nucleic Acids Research|August 1, 2006
Ancient origin, functional conservation and fast evolution of DNA-dependent RNA polymerase IIIGalina M Proshkina, Elena K Shematorova, Sergey A Proshkin, et al.
Theranostics|December 7, 2013
Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitroKristina E Mironova, Galina M Proshkina, Anastasiya V Ryabova, et al.
ACS Omega|June 28, 2021
Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier DeliveryVictoria O Shipunova, Olga A Kolesnikova, Polina A Kotelnikova, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 13, 2023
HER2-specific liposomes loaded with proteinaceous BRET pair as a promising tool for targeted self-excited photodynamic therapyElena I Shramova, Victoriya P Filimonova, Anastasiya Yu Frolova, et al.
Light, Science & Applications|February 22, 2022
Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumorsElena I Shramova, Stepan P Chumakov, Victoria O Shipunova, et al.
Cancers|October 23, 2021
DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in MiceGalina M Proshkina, Elena I Shramova, Marya V Shilova, et al.
ACS Nano|September 16, 2020
Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer TreatmentVictoria O Shipunova, Elena N Komedchikova, Polina A Kotelnikova, et al.
Biochimie|July 23, 2025
Genetically modified NK cells equipped with a switchable CAR for the treatment of HER2-positive cancersMaria A Streltsova, Anna A Boyko, Nadezhda A Alekseeva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nanomaterials (Basel, Switzerland)|December 24, 2025
DNA Unwinding Driven by Gold NanoparticlesLiat Katrivas, Galina M Proshkina, Sergey M Deyev, et al.
Nucleic Acids Research|August 1, 2006
Ancient origin, functional conservation and fast evolution of DNA-dependent RNA polymerase IIIGalina M Proshkina, Elena K Shematorova, Sergey A Proshkin, et al.
Theranostics|December 7, 2013
Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitroKristina E Mironova, Galina M Proshkina, Anastasiya V Ryabova, et al.
ACS Omega|June 28, 2021
Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier DeliveryVictoria O Shipunova, Olga A Kolesnikova, Polina A Kotelnikova, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 13, 2023
HER2-specific liposomes loaded with proteinaceous BRET pair as a promising tool for targeted self-excited photodynamic therapyElena I Shramova, Victoriya P Filimonova, Anastasiya Yu Frolova, et al.
Light, Science & Applications|February 22, 2022
Genetically encoded BRET-activated photodynamic therapy for the treatment of deep-seated tumorsElena I Shramova, Stepan P Chumakov, Victoria O Shipunova, et al.
Cancers|October 23, 2021
DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in MiceGalina M Proshkina, Elena I Shramova, Marya V Shilova, et al.
ACS Nano|September 16, 2020
Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer TreatmentVictoria O Shipunova, Elena N Komedchikova, Polina A Kotelnikova, et al.
Biochimie|July 23, 2025
Genetically modified NK cells equipped with a switchable CAR for the treatment of HER2-positive cancersMaria A Streltsova, Anna A Boyko, Nadezhda A Alekseeva, et al.
Pageof 1